Moreover, the anticancer activity of oxaliplatin incorporated into nano-emulsion containing TPO oil was evaluated in vitro in a p53 wild-type human colon cancer cell line HCT116 and a p53 mutant human colon cancer cell line, HT-29. The gene discussed is TP53; the disease is malignant colon neoplasm.